血清素受体的阿洛斯特基调节剂:一种药物化学调查
Leonardo Brunetti1, Fabio Francavilla1, Marcello Leopoldo1
1Department of Pharmacy-Drug Sciences, University of Bari Aldo Moro, 70125 Bari, Italy.
本综述探讨了血清素受体的全联体,重点是5-HT2C受体的天然化合物和合成调节剂. 这些全调节剂为诸如肥胖等疾病提供了传统药物潜在的更安全的替代品.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 药用化学 医学化学
背景情况:
- 血清素 (5-基三胺,5-HT) 是一个关键的神经递质,与各种生理功能和精神分裂症,抑郁症,偏头痛和肥胖等疾病有关.
- 血清激素受体 (5-HTRs),主要是G蛋白合受体 (GPCRs),表现出高度的同质性,导致与传统的正联体产生副作用.
- 需要更安全的治疗药物,需要开发接剂,以向血清激素受体上较少保存的全位.
研究的目的:
- 审查用于血清素受体的全联体的识别和表征.
- 要突出天然化合物和合成调节剂,特别是对于5-HT2C受体.
- 讨论全调节剂作为更安全的治疗剂的潜力,特别是针对肥胖症.
主要方法:
- 对已识别的血清素受体的全性配体进行文献综述.
- 分析天然化合物 (如胺,大麻,THC,阿波芬类化合物) 和合成调节剂.
- 检查在全性结合位点上的联结体受体相互作用.
主要成果:
- 识别各种天然化合物和合成调节剂,作为血清素受体的全配体.
- 专注于5-HT2C受体的阳性全调节剂 (PAMs),显示出对抗肥胖应用的希望.
- 详细的洞察力,在可用的地方,在全位的配体受体相互作用.
结论:
- 亚洛斯特连接物代表了开发更安全的药物向血清素受体的有希望的途径.
- 5-HT2C受体PAMs为管理肥胖提供了潜在的改善治疗特征.
- 需要进一步研究血清素受体的全调节.
更多相关视频
07:41A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
Published on: February 20, 2018
08:49Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome
Published on: September 23, 2015
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Drugs Affecting Neurotransmitter Release or Uptake
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Allosteric Regulation
